Pancreatic phenotype in infants with cystic fibrosis identified by mutation screening

Cipolli, Marco; Castellani, Carlo; Wilcken, Bridget; Massie, John; McKay, Karen; Gruca, Margie; Tamanini, Anna; Assael, Maurice Baroukh; Gaskin, Kevin
October 2007
Archives of Disease in Childhood;Oct2007, Vol. 92 Issue 10, p842
Academic Journal
Objective: To determine the pancreatic phenotype of infants with cystic fibrosis (CF) diagnosed in the first week of life by a combined immunoreactive trypsin/mutation screening program. Design: A prospective evaluation of pancreatic function in infants with CF at the time of neonatal diagnosis and up to the age of 12. Setting: Two different centres (Verona, Italy and Westmead, Australia) to enable comparison of results between two regions where <60% or ⩾90% of patients, respectively, have at least one single ΔF508 a mutation. Patients: 315 children with CF including 149 at Verona and 166 at Westmead. Interventions: Fat balance studies over 3-5 days and pancreatic stimulation tests with main outcome measures being faecal fat or pancreatic colipase secretion. Patients with malabsorption are pancreatic insufficient (P1) or with normal absorption and pancreatic sufficient (PS). Results: 34 infants (23%) at Verona and 46 (28%) at Westmead were PS at diagnosis. 15% of those with two class I, II or III ‘severe’ mutations and 26⁄28 (93%) of those with class IV or V mutations were PS at this early age. Of the 80 infants with PS, 20 became P1 before the age of 12. All 20 had two severe mutations. Conclusion: Neonatal mutational screening programs for CF are less likely to detect PS patients with non-ΔF508 mutations. Of PS patients who are detected, those with two severe class I, II or III mutations are at particularly high risk of becoming PI during early childhood.


Related Articles

  • Cystic fibrosis with homozygous R553X mutation in a Taiwanese child. Hui-Ju Chen; Shuan-Pei Lin; Hung-Chang Lee; Chih-Ping Chen; Nan-Chang Chiu; Han-Yang Hung; Schu-Rern Chern; Chih-Kuang Chuang // Journal of Human Genetics;Dec2005, Vol. 50 Issue 12, p674 

    It has been reported that cystic fibrosis is very rare in Asians, and its clinical expression and genetic mutations are different from those found in Caucasians. We report the case of a boy who had chronic diarrhea with failure to thrive and frequent respiratory tract infections beginning at the...

  • Kids in America: Newborn Screening for Cystic Fibrosis. Bender, Laura M.; Cotten, Steven W.; Willis, Monte S. // Laboratory Medicine;Oct2011, Vol. 42 Issue 10, p595 

    Within the last year, all 50 states in the United States have adopted newborn screening (NBS) protocols for cystic fibrosis (CF), the most common fatal autosomal recessive disease among Caucasian populations. In this overview, we discuss the rationale for implementing NBS for CF and discuss the...

  • The geographic distribution of cystic fibrosis mutations gives clues about population origins. Dawson, K. P.; Frossard, P. M. // European Journal of Pediatrics;2000, Vol. 159 Issue 7, p496 

    Unlabelled: Information regarding three of the more common cystic fibrosis mutations is presented (delta F508, G542X, N13031K) to support the concept of a geography associated with cystic fibrosis mutations. We present the hypothesis that a knowledge of the geography of cystic...

  • Screening of CFTR mutations in an isolated population: identification of carriers and patients. Chiba-Falek, Ornit; Nissim-Rafinia, Malka; Argaman, Zvi; Genem, Adnan; Moran, Ilana; Kerem, Eitan; Kerem, Batsheva // European Journal of Human Genetics;Mar1998, Vol. 6 Issue 2, p181 

    One important application of the identification of disease-causing mutations is carrier screening in the general population. Such a project requires a simple accurate test by which a large proportion of the mutations can be identified. This study describes screening for CFTR mutations in an...

  • What and when to collect from infants with cystic fibrosis. Doull, Lolo // Archives of Disease in Childhood;Oct2007, Vol. 92 Issue 10, p831 

    The article presents two studies which examine cystic fibrosis (CF) in children. The first study assesses CF through newborn screening, where developmental disabilities were found to be dependent on genotype while the second study evaluates the value of flexible bronchoscopy in obtaining...

  • Early and late outcome of cystic fibrosis screening. Green, M. R.; Weaver, L. T. // Journal of the Royal Society of Medicine (Supplement);Jan1994, Vol. 87 Issue 21, p5 

    The article focuses on the outcome of cystic fibrosis (CF) screening by blood immunoreactive trypsin assay in East Anglia, England in 1980. Information on the screening process is provided. Incidence of CF in the region in terms of genotype and birth order is explored as well as the factors that...

  • Impact of molecular biology on clinical genetics. Pembrey, Marcus // British Medical Journal (Clinical Research Edition);9/19/1987, Vol. 295 Issue 6600, p711 

    Examines the impact of molecular biology on clinical genetics. Use deoxyribonucleic acid probes to analyze mutations; Analysis of DNA in prenatal diagnosis of haemoglobinopathies; Discussions on cystic fibrosis mapping.

  • Early acute pancreatitis in a child with compound heterozygosis ΔF508/R1438W/Y1032C cystic fibrosis: a case report. Leonardi, Salvatore; Domenico Praticò, Andrea; Rotolo, Novella; Di Dio, Giovanna; Lionetti, Elena; La Rosa, Mario // Journal of Medical Case Reports;2013, Vol. 7 Issue 1, p1 

    Introduction: Recent studies suggest an important role of the cystic fibrosis transmembrane conductance regulator gene in the development of pancreatitis. It occurs approximately in 20% of patients with cystic fibrosis and almost exclusively in pancreatic sufficient people. Newborn screening and...

  • Hereditary haemochromatosis mutation frequencies in the general population. Bradley, Linda A.; Johnson, Dorene D.; Palomaki, Glenn E.; Haddow, James E.; Robertson, Nancy H.; Ferrie, Richard M. // Journal of Medical Screening;Mar1998, Vol. 5 Issue 1, p34 

    Objectives This study aims to expand our knowledge of the general population frequency of two mutations, C282Y and H63D, identified in the candidate gene for hereditary haemochromatosis, and to determine whether the testing can be performed using routinely obtained cheek-brush (buccal) samples....


Read the Article

Other Topics